Regencell Bioscience (RGC) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Regencell Bioscience (RGC) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Regencell Bioscience

· RGC

Dashboard

Financials

Ratios

Valuation

Statistics

3.072 B

+0.32%

General

Market Cap: $3.07B
Enterprise Value: $3.08B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -233.91%
ROE: -231.87%
ROIC: -444.21%
Current Ratio: 1.42
Debt-to-Equity: 0.32
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 2527.38
EV/EBITDA: -438.09

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $7.09M
Operating Income: -$7.13M
Net Profit: -$7.05M

Balance Sheet

Cash and Equivalents: $2.36M
Working Capital: $691.39K
Total Assets: $3.01M
Net Debt: -$1.97M
Total Liabilities: $1.79M
Total Equity: $1.22M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$2.59M
Cash Flow from Investing: $2.5M
Cash Flow from Financing: —
Free Cash Flow: -$2.59M
Capital Expenditures: $2